Palliative treatment of unresectable bile duct cancer: Which stent? Which approach?

David C. Madoff; Michael J. Wallace

doi:10.1016/S1055-3207(02)00037-6

Palliative treatment of unresectable bile duct cancer: Which stent? Which approach?

David C. Madoff, Michael J. Wallace

Interventional Radiology

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Nonsurgical options for the palliative treatment of unresectable bile duct cancer are discussed. Despite all of the available approaches, the disease remains uniformly fatal. The goal of managing unresectable bile duct cancer is to treat the symptoms that still contribute to significant morbidity and mortality. Further development of new treatment strategies and modalities is needed to improve the quality of life and survival of patients with this disease.

Original language	English (US)
Pages (from-to)	923-939
Number of pages	17
Journal	Surgical oncology clinics of North America
Volume	11
Issue number	4
DOIs	https://doi.org/10.1016/S1055-3207(02)00037-6
State	Published - Oct 2002

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1016/S1055-3207(02)00037-6

Cite this

@article{2fca8eabb3c345a0b8c5a2de761465c7,

title = "Palliative treatment of unresectable bile duct cancer: Which stent? Which approach?",

abstract = "Nonsurgical options for the palliative treatment of unresectable bile duct cancer are discussed. Despite all of the available approaches, the disease remains uniformly fatal. The goal of managing unresectable bile duct cancer is to treat the symptoms that still contribute to significant morbidity and mortality. Further development of new treatment strategies and modalities is needed to improve the quality of life and survival of patients with this disease.",

author = "Madoff, {David C.} and Wallace, {Michael J.}",

year = "2002",

month = oct,

doi = "10.1016/S1055-3207(02)00037-6",

language = "English (US)",

volume = "11",

pages = "923--939",

journal = "Surgical oncology clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Palliative treatment of unresectable bile duct cancer

T2 - Which stent? Which approach?

AU - Madoff, David C.

AU - Wallace, Michael J.

PY - 2002/10

Y1 - 2002/10

N2 - Nonsurgical options for the palliative treatment of unresectable bile duct cancer are discussed. Despite all of the available approaches, the disease remains uniformly fatal. The goal of managing unresectable bile duct cancer is to treat the symptoms that still contribute to significant morbidity and mortality. Further development of new treatment strategies and modalities is needed to improve the quality of life and survival of patients with this disease.

AB - Nonsurgical options for the palliative treatment of unresectable bile duct cancer are discussed. Despite all of the available approaches, the disease remains uniformly fatal. The goal of managing unresectable bile duct cancer is to treat the symptoms that still contribute to significant morbidity and mortality. Further development of new treatment strategies and modalities is needed to improve the quality of life and survival of patients with this disease.

UR - http://www.scopus.com/inward/record.url?scp=0036812456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036812456&partnerID=8YFLogxK

U2 - 10.1016/S1055-3207(02)00037-6

DO - 10.1016/S1055-3207(02)00037-6

M3 - Review article

C2 - 12607580

AN - SCOPUS:0036812456

SN - 1055-3207

VL - 11

SP - 923

EP - 939

JO - Surgical oncology clinics of North America

JF - Surgical oncology clinics of North America

IS - 4

ER -

Palliative treatment of unresectable bile duct cancer: Which stent? Which approach?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this